USPTO 2015–2025 USPTO PatentsView US Corporation

Joint Development, Inc.

USPTO PatentsView assignee record - 19 granted patents across 5 technology areas, recorded in grant years 2016–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device).

RSS updates for this company

The verdict

According to USPTO PatentsView, Joint ranks #15,399 of 49,997 tracked US assignees by granted-patent volume, with 19 patents across 5 technology areas.

#15,399
of 49,997 US assignees by volume
33rd percentile
by Innovation Score (30.0/100)
10.3
avg claims per patent
+43%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R15399 · US Corporation #15,399 · 19 grants

GRANTS-MICRO · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-UP · BOOK-FULL

  • GRANTS-MICRO 19 grants
  • MID-PACK #15,399/49,997
  • PHOTO-FINISH Jeisys Medical
  • CPC-NARROW A61F · 5 areas
  • INNOV-THIN 30.0/100
  • CLAIMS-PAR 10.3 claims/avg
  • TYPE-USCORP US Corporation
  • VEL-UP +43% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Jeisys Medical Inc. (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Joint’s 30.0 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Joint

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Joint's Innovation Score is 30.0/100 (33rd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Joint?

Each dot is one of Joint’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Joint’s own 10.3 claims/patent is at or below the 10.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Joint vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 18.918.91919.1 0510152025 Granted patents (volume) Avg claims / patent Jeisys Medical Inc. - 19, 11.16Jeisys MedicalJenKem Technology Co., Ltd. (Tianjin) - 19, 15Jenkem Technology…Jiashan Sansi Optoelectronic Technology Co. Ltd. - 19, 7.58Jiashan Sansi Opt…Johnan Manufacturing Inc. - 19, 5.26Johnan Manufactur…Joint Stock Company “Science and Innovations” - 19, 8.53Joint Stock “Scie…JumpCloud, Inc. - 19, 19.37JumpcloudKaken Pharmaceutical Co., Ltd. - 19, 12.74Kaken Pharmaceuti…Kawasaki Railcar Manufacturing Co., Ltd. - 19, 10.63Kawasaki Railcar…Joint Development, Inc. - 19, 10.32Joint Development
Joint vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Joint's grants concentrate

Joint Development, Inc. is a focused PatentsView assignee: 5 CPC subclasses with 42.1% of grants classified under A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device). Peak complete grant year is 2016 (5 grants) versus a trough of 1 in 2017. By volume, Joint sits between Jeisys Medical Inc. and Kawasaki Railcar Manufacturing Co., Ltd..

Joint's three-year grant acceleration

Joint Development, Inc. shows 5 grants in 2022–2024 against only 6 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at Joint's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows Joint holds 19 patents at rank #15,398, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near Joint

By rank, the assignees closest to #15,398 in granted patent volume.

Leaders in A61F (Filters Implantable Into Blood Vessels)

Other assignees with the most granted patents in Joint's primary technology class.

Joint's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 33rd percentile higher than 33% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

0123456 20162017201920202021202220242025 2
USPTO utility patent grants by year · 2016–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2016–2019 baseline. Full figures in the table below.

View data table
Joint Development, Inc. patent grants by year, 2015–2025
Year Patents Granted Share of Period
2016 5 26.3%
2017 1 5.3%
2019 1 5.3%
2020 3 15.8%
2021 2 10.5%
2022 1 5.3%
2024 4 21.1%
2025partial year 2 10.5%

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

Joint Development, Inc.'s patent record in context - here's where to go next.

  • Joint Development, Inc.'s lead technology class is A61F (Filters Implantable Into Blood VESSELS; PROSTHESES; Devices Providing Patency TO, OR Preventing Collapsing OF, Tubular Structures OF THE Body, e.g. STENTS; Orthopaedic, Nursing OR Contraceptive Device), 42.1% of its portfolio - see every assignee active in that class. Explore A61F
  • Ranked #15,399 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare Joint Development, Inc. against Jeisys Medical Inc., an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 30.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.